October 28, 2025
Mexico City – Discussions continue between Cuba and Mexico concerning a possible procurement of the Abdala Coronavirus vaccine for the upcoming winter season. This progress comes as Cuba concurrently prepares for a crucial vote at the United Nations addressing the longstanding United States embargo against the island nation.
Ongoing Negotiations and Evolving Circumstances
According to statements released by Cuban Ambassador to Mexico, Marcos Rodríguez Costa, the two governments are actively evaluating the feasibility of the vaccine agreement. He indicated that factors have changed as previous successful transactions. “Currently,there is another situation,so both governments are continuing to analyze this collaboration,” Ambassador Rodríguez Costa explained.
The diplomat emphasized that Mexican authorities are well aware of the Abdala vaccine’s proven effectiveness, citing its positive impact during the height of the Covid-19 pandemic, where it was administered to thousands of individuals within mexico. Despite its prior success, the current scenario necessitates a reevaluation of the potential collaboration.
Abdala Vaccine’s Proven Efficacy
Mexican health officials previously acknowledged the Abdala vaccine’s 93 percent efficacy rate, highlighting it as one of only two vaccines globally supported by full population-based scientific studies-not solely relying on experimental data. This recognition played a key role in previous acquisition decisions.
While Mexico initially purchased substantial quantities of the Abdala vaccine-9 million doses at the close of 2022 and an additional 7 million doses spanning late 2023 and early 2024 during the management of President Andrés Manuel López Obrador-no new procurement orders have been placed this year.
Here’s a summary of previous Abdala vaccine acquisitions by Mexico:
| Year | doses Acquired |
|---|---|
| 2022 | 9 Million |
| 2023-2024 | 7 Million+ |
| 2025 | None (as of October 28, 2025) |
Did You Know? The Abdala vaccine utilizes a protein subunit technology, a well-established approach used in other successful vaccines like Hepatitis B and HPV.
Geopolitical Context and UN Vote
The discussions surrounding the Abdala vaccine are occurring alongside Cuba’s push for a United Nations resolution condemning the U.S. embargo. This long-standing trade blockade has significantly impacted the Cuban economy,including its ability to access essential medical supplies and technologies.
Pro Tip: stay informed about global health developments by consulting reputable sources like the World Health Organization (https://www.who.int/) and the Pan American Health Organization (https://www.paho.org/).
Vaccine Diplomacy and Global health Security
The situation between Cuba and Mexico exemplifies the role of ‘vaccine diplomacy’ in international relations. Access to vaccines, especially during a pandemic, can significantly impact a nation’s health security and its standing on the global stage. The Abdala vaccine, developed by cuba’s BioCubaFarma, represents a meaningful achievement for the country’s biotechnology sector.
Global health security has come under increased scrutiny following the Covid-19 pandemic. Nations are now more aware of the interconnectedness of health crises and the importance of collaboration in vaccine development, production, and distribution.The ongoing negotiations between Cuba and Mexico underscore the complexities involved in ensuring equitable access to vital medical resources.
Frequently Asked Questions About the Abdala Vaccine
- What is the Abdala vaccine? The Abdala vaccine is a Covid-19 vaccine developed by Cuba’s BioCubaFarma,utilizing a protein subunit technology.
- How effective is the Abdala vaccine? Mexican health authorities have recognized the Abdala vaccine as 93 percent effective.
- Has Mexico purchased the Abdala vaccine previously? Yes, Mexico acquired 9 million doses in 2022 and over 7 million doses in 2023-2024.
- Why are negotiations continuing for a 2025 purchase? Current circumstances have changed, requiring both governments to reassess the collaboration.
- What is the connection to the UN vote? Cuba is seeking a UN resolution condemning the U.S. embargo, which impacts its access to medical resources.
What impact will this decision have on Cuba’s vaccine production capabilities? And how might this situation affect broader regional health collaborations in Latin America?
Share your thoughts in the comments below, and don’t forget to share this article with your network!
